Bioxis Pharmaceuticals

About:

France-based developer of Monophasic Tissular inductor MTI12

Top Investors: Waarde Capital, Juvamed

Description:

The company, which is certified ISO 13485, has 10 employees, including senior management with extensive experience from major players in aesthetic dermatology. It has received the support from Medicen, the life sciences cluster of the Paris Region (EIP label) as well as BPI France (French public investment bank).

Total Funding Amount:

2.5M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2010-01-01

Founders:

Frédéric Bertaïna

Number of Employees:

11-50

Last Funding Date:

2016-09-23

IPO Status:

Private

Industries: